Generics Cos. Prevail In AstraZeneca's Crestor Suit
A federal judge has ruled that AstraZeneca Pharmaceuticals LP can not use two method patents to block generic versions of its blockbuster cholesterol drug Crestor, a decision that could shorten the...To view the full article, register now.
Already a subscriber? Click here to view full article